Related Experiment Videos
Gastric and small bowel lymphoma.
The Surgical Clinics of North America
|August 1, 1986
Summary
Surgical resection improves survival for early-stage gastric and small bowel lymphoma. For advanced disease, debulking surgery aids chemotherapy effectiveness and prevents complications, offering the best outcome with multimodality therapy.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Hematology
Background:
- Gastric and small bowel lymphomas often present with non-specific symptoms.
- The incidence of non-Hodgkin's lymphoma is increasing, partly due to immunodeficiency disorders.
Purpose of the Study:
- To evaluate the role of surgical resection and debulking in the management of gastric and small bowel lymphoma.
- To emphasize the importance of multimodality therapy for optimal patient outcomes.
Main Methods:
- Review of surgical management strategies for gastric and small bowel lymphoma.
- Analysis of the impact of surgical debulking on chemotherapy response and complications.
Main Results:
- Adequate surgical resection of stage I disease can achieve survival.
- Surgical debulking of advanced disease enhances chemotherapy response and prevents complications like perforation and obstruction.
- Nutritional support is crucial for patients undergoing chemotherapy.
Conclusions:
- Multimodality therapy, including surgical resection and/or debulking, offers the best chance for successful outcomes in gastric and small bowel lymphoma.
- Surgical intervention should complement, not preclude, chemotherapy and radiation therapy when appropriate.